![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chongqing Huapont Pharmaceutical Co., Ltd. Chongqing Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Acitretin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2005-226 - Rev 00
This Chemical Type CEP, issued on February 27, 2008, remains in force until December 21, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 1385 associated with this CEP further emphasizes